Mineralys Therapeutics, Inc. (MLYS)

Typically moves ±6.09% on earnings

EARNINGS ANALYTICS

event_upcoming Next Earnings: 2026-08-12 HIGH CONFIDENCE

Across 14 earnings reports since Mar 15, 2023, Mineralys Therapeutics, Inc. (MLYS) has a clear post-earnings pattern. It moves ±6.09% on average after reporting and finishes higher 35.7% of the time. Its largest post-earnings gain was +10.04% (Feb 12, 2025) and its largest decline was -22.82% (Aug 13, 2024). The next earnings report is predicted for 2026-08-12 (high confidence).

Earnings reactions

How MLYS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.09%

Positive %

35.7%

Negative %

64.3%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 06, 2026	☽ POST	-2.62%	open_in_new
Mar 12, 2026	☽ POST	-2.96%	open_in_new
Nov 10, 2025	☽ POST	+5.87%	open_in_new
Aug 12, 2025	☽ POST	+0.37%	open_in_new
May 12, 2025	☽ POST	+1.2%	open_in_new
Feb 12, 2025	☀ PRE	+10.04%	open_in_new
Nov 12, 2024	☀ PRE	-10.32%	open_in_new
Aug 13, 2024	☽ POST	-22.82%	open_in_new
May 09, 2024	☀ PRE	-2.59%	open_in_new
Mar 21, 2024	☀ PRE	-2.24%	open_in_new
Nov 07, 2023	☽ POST	-6.74%	open_in_new
Aug 07, 2023	☽ POST	+6.96%	open_in_new
May 15, 2023	☽ POST	-4.57%	open_in_new
Mar 15, 2023	☽ POST	-5.93%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.09%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 19 →

Funds holding

$344251196

Total value held

Buying

11 added · 7 reduced

Blackrock, Inc.

$121406057 +3.56%

State Street Corp

$79534615 -7.82%

Franklin Resources Inc

$48346494 -0.23%

Bank Of America Corp /De/

$29809078 +11.45%

Morgan Stanley

$23004437 +32.79%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260723	open_in_new SEC.gov
144	20260721	open_in_new SEC.gov
4	20260720	open_in_new SEC.gov
144	20260717	open_in_new SEC.gov
144	20260715	open_in_new SEC.gov
4	20260715	open_in_new SEC.gov
4	20260715	open_in_new SEC.gov
144/A	20260714	open_in_new SEC.gov
144	20260713	open_in_new SEC.gov
144	20260713	open_in_new SEC.gov

Frequently asked about MLYS earnings

When does Mineralys Therapeutics, Inc. report earnings next? expand_more

Mineralys Therapeutics, Inc. (MLYS)'s next earnings date is predicted (high confidence) for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does MLYS stock move after earnings? expand_more

Over 14 reports, MLYS has moved an average of ±6.09% the session after earnings, closing higher 35.7% of the time.

What was MLYS's biggest post-earnings move? expand_more

MLYS's largest post-earnings gain on record was +10.04% on Feb 12, 2025, and its largest decline was -22.82% on Aug 13, 2024.

Where can I find Mineralys Therapeutics, Inc.'s SEC filings? expand_more

All of Mineralys Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.